News

Filter

Current filters:

Bausch & Lomb

1 to 9 of 81 results

Nicox and Bausch + Lomb to co-promote latanoprostene bunod for glaucoma

Nicox and Bausch + Lomb to co-promote latanoprostene bunod for glaucoma

08-08-2014

International opthalmic company Nicox is to co-promote latanoprostene bunod with Bausch + Lomb, the eyecare…

Bausch & LombCanadaGlaucomaLatanoprost OphthalmicMarkets & MarketingNicOxOphthalmicsOpticsPharmaceuticalUSA

Valeant Pharma returns to profit, boosted by B&L acquisition

27-02-2014

Canadian drugmaker Valeant Pharmaceuticals International has announces fourth quarter financial results…

Bausch & LombFinancialGenericsValeant Pharmaceuticals

Valeant Pharma beats forecasts, turns in profit

07-08-2013

Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) announced second quarter financial…

Bausch & LombFinancialGenericsValeant Pharmaceuticals

Bausch & Lomb options license to DES compound

18-07-2013

US eye health giant Bausch & Lomb (NYSE: BOL) says it has acquired an option to license an investigational…

Bausch & LombLicensingMIM-D3Mimetogen PharmaceuticalsOphthalmicsPharmaceutical

Valeant confirms plan to acquire Bausch & Lomb in a $8.7 billion transaction

28-05-2013

Following speculation ahead of the extended holiday weekend, acquisitive Canadian drugmaker Valeant Pharmaceuticals…

Bausch & LombMergers & AcquisitionsOphthalmicsPharmaceuticalValeant Pharmaceuticals

Bausch & Lomb said to be on the block for $10 billion

13-12-2012

A Bloomberg report says that Warburg Pincus, which acquired the business in 2007, has appointed Goldman…

Bausch & LombMergers & AcquisitionsOphthalmicsPharmaceutical

1 to 9 of 81 results

COMPANY SPOTLIGHT

Menarini

Back to top